3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
4
Rectal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Solid Malignant Tumors
1
Sarcoma, Ewing
1
Sarcoma
1
Recurrence
1
Piebaldism
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Glioblastoma
1
Disease Progression
1
Cholangiocarcinoma
1
Bone Neoplasms
1
Interventions
pembrolizumab
12
Cisplatin
11
Specimen Handling
9
Bevacizumab
7
Brachytherapy
6
Platinum
5
Paclitaxel
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Human Papillomavirus DNA Tests
5
Colposcopy
5
Carboplatin
5
atezolizumab
4
Gemcitabine
4
Fulvestrant
4
Surveys and Questionnaires
3
Radiotherapy
3
Radiation Dose Hypofractionation
3
Radiation
3
Drug Therapy
3
Blood Specimen Collection
3
1,2-diaminocyclohexaneplatinum II citrate
3
tisotumab vedotin
2
palbociclib
2
lenvatinib
2
Topotecan
2
Restraint, Physical
2
Radiotherapy, Intensity-Modulated
2
Pemetrexed
2
Magnetic Resonance Imaging
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
regorafenib
×
90 days
×
Clear all
No trials found.